Hypouricemia and tubular transport of uric acid;Hipouricemia y manejo renal del ácido úrico

Nefrologia

Volumn 31, Issue 1, 2011, Pages 44-50

  Martín, Noemí Esparza ^a   Nieto, V García ^b  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

Hypouricemia; Renal tubular transport of uric acid

Indexed keywords

GLUCOSE TRANSPORTER; ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER; SLC22A12 PROTEIN, HUMAN; SLC2A9 PROTEIN, HUMAN; URIC ACID; XANTHINE; XANTHINE OXIDASE;

ABSORPTION; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; FLUID THERAPY; GENETICS; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DISORDER; METABOLISM; PREVALENCE; RENAL HYPOURICEMIA; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; URINE; UROLITHIASIS;

ABSORPTION; BIOLOGICAL TRANSPORT; DIABETES COMPLICATIONS; DIAGNOSIS, DIFFERENTIAL; FLUID THERAPY; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; KIDNEY TUBULES, PROXIMAL; MODELS, BIOLOGICAL; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; PREVALENCE; RENAL TUBULAR TRANSPORT, INBORN ERRORS; URIC ACID; URINARY CALCULI; XANTHINE; XANTHINE OXIDASE;

EID: 79751515913     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Oct.10588     Document Type: Review

References (71)

1. García Nieto V, Luis Yanes MI, Callejón A. Disfunción tubular proximal renal en la diabetes mellitus insulino-dependiente. Nefrologia 2001;21(Supl 3):32-8.
2. Shichiri M, Iwamoto H, Shiigai T. Diabetic renal hypouricemia. Arch Intern Med 1987;147:225-8.
3. Simkin PA, Hoover PL, Paxson CS, Wilson WF. Uric acid excretion: quantitative assessment from spot, midmorning serum and urine samples. Ann Intern Med 1979;91:44-7.
4. a ed.). Madrid: Aula Médica, 2006;39-49.
5. Rieselbach RE, Steele TH. Influence of the kidney upon urate homeostasis in health and disease. Am J Med 1974;56:665-75.
6. Berliner RW, Hilton JG, Yu TF, Kennedy TJ. The renal mechanism for urate excretion in man. J Clin Invest 1950;29:396-401.
7. Praetorius E, Kirk JE. Hypouricemia: With evidence for tubular elimination of uric acid. J Lab Clin Med 1950;35:865-8.
8. Gutman AB, Yu TF. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med 1957;23:600-22.
9. Gutman AB, Yu TF. A three-component system for regulation of renal excretion of uric acid in man. Trans Assoc Am Physicians 1961;74:353-65.
10. Diamond HS, Paolino JS. Evidence for a postsecretory reabsorptive site for uric acid in man. J Clin Invest 1973;52:1491-9.
11. Muñoz Sanz A, García Puig J, Mateos F, Barbado FJ. Fisiopatología renal del ácido úrico. Estudio farmacológico. Med Clin (Barc) 1982;78:70-4.
12. Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol 2007;19:151-7.
13. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002;417:447-52.
14. Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Arch 2004;447:666-76.
15. Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004;15:164-73.
16. Komoda F, Sekine T, Inatomi J, Enomoto A, Endou H, Ota T, et al. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol 2004;19:728-33.
17. Ichida K, Hosoyamada M, Kamatani N, Kamitsuji S, Hisatome I, Shibasaki T, et al. Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese. Clin Genet 2008;74:243-51.
18. Cheong HI, Kang JH, Lee JH, Ha IS, Kim S, Komoda F, et al. Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr Nephrol 2005; 20:886-90.
19. Dinour D, Gafter U, Knecht A, Rachamimov R, Serban I, Holzman EJ. Novel missense mutations in the Urat1 gene are associated with renal hypouricemia in Iraqui-Jews. J Am Soc Nephrol 2004;15:89A.
20. Nindita Y, Hamada T, Bahrudin U, Hosoyamada M, Ichida K, Iwai C, et al. Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA. Arzneimittelforschung 2010;60:186-8.
21. Jutabha P, Kanai Y, Hosoyamada M, Chairoungdua A, Kim DK, Iribe Y, et al. Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem 2003;278:27930-8.
22. Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 2008;283:26834-8.
23. Phay JE, Hussain HB, Moley JF. Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 2000;66:217-20.
24. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): Alternative splicing alters trafficking. J Biol Chem 2004;279:16229-36.
25. Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K, et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 2008;83:744-51.
26. Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, Richardson W, et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 2010;21:64-72.
27. Preitner F, Bonny O, Laverrière A, Rotman S, Firsov D, Da Costa A, et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci USA 2009;106:15501-6.
28. Li S, Sanna S, Maschio A, Maschio A, Busonero F, Usala G, et al. The GLUT9 gene is associated with serum uric levels in Sardinia and chianti cohorts. PLoS Genet 2007;3:e194.
29. Brandstätter A, Kiechl S, Kollerits B, Hunt SC, Heid IM, Coassin S, et al. The gender-specific association of the putative fructose transporter SLC2A9 variants with uric levels is modified by BMI. Diabetes Care 2008;31:1662-7.
30. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration and gout. Nat Genet 2008;40:437-42.
31. Polasek O, Gunjaca G, Kolciç I, Zgaga L, Dzijan S, Smoliç R, et al. Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study for glucose transporter type 9 (SLC2A9): study of 145 patients. Croat Med J 2010;51:48-53.
32. Guggino SE, Aronson PS. Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog renal microvillus membranes. J Clin Invest 1985;76:543-7.
33. Kahn AM. Indirect coupling between sodium and urate transport in the proximal tubule. Kidney Int 1989;36:378-84.
34. Coady MJ, Chang MH, Charron FM, Plata C, Wallendorff B, Sah JF, et al. The human tumour suppressor gene SLC5A8 expresses a Namonocarboxylate cotransporter. J Physiol 2004;557:719-31.
35. Gopal E, Fei YJ, Miyauchi S, Zhuang L, Prasad PD, Ganapathy V. Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. Biochem J 2005;388:309-16.
36. Padova J, Bendersky G. Hyperuricemia in diabetic ketoacidosis. N Engl J Med 1962;267:530-4.
37. Lieber CS, Jones DP, Losowsky MS, Davidson CS. Interrelation of uric acid and ethanol metabolism in man. J Clin Invest 1962;41:1863-70.
38. Cullen JH, Levine M, Fiore JM. Studies of hyperuricemia produced by pyrazinamide. Am J Med 1957;23:587-95.
39. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993;270:354-9.
40. Ter Maaten JC, Voorburg A, Heine RJ, Ter Wee PM, Donker AJ, Gans RO. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997;92:51-8.
41. Mount DB. Molecular physiology and the four-component model of renal urate transport. Curr Opin Nephrol Hypertens 2005;14:460-3.
42. Xu G, Bhatnagar V, Wen G, Hamilton BA, Eraly SA, Nigam SK. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int 2005;68:1491-9.
43. Ramsdell CM, Kelly WN. The clinical significance of hypouricemia. Ann Intern Med 1973;78:239-42.
44. a ed.). New York: McGraw Hill, 1989;2605-19.
45. Yanase M, Nakahama H, Mikami H, Fukuhara Y, Orita Y, Yoshikawa H. Prevalence of hypouricemia in apparently normal population. Nephron 1988;48:80.
46. Lawee D. Uric acid: The clinical application of 1000 unsolicited determinations. Canad Med Ass J 1969;100:838-41.
47. Moriwaki Y, Yamamoto T, Takahashi S, Hiroishi K, Yamakita J, Nasako Y, et al. Uric acid transport in Fanconi syndrome with marked renal hypouricemia: Analysis using pyrazinamide and benzbromarone. Nephron 1996;74:452-3.
48. Bodier L, Blanchard A, Sarret D, Hérody M, Nédèlec G, Duvic C. Hypouricemia, an old subject and new concepts. Presse Med 2004;24:555-63.
49. Gibson T, Sims HP, Jimenez SA. Hipouricaemia and increased renal urate clearance associated with hyperparathyroidism. Ann Rheum Dis 1976;35:372-6.
50. Sonnenblick M, Rosin AJ: Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatremia. Postgrad Med J 1986;62:449-52.
51. Schlosstein L, Kippen I, Bluestone R, Whitehouse MW, Klininberg JR. Association between hypouricaemia and jaundice. Ann Rheum Dis 1974;33:308-12.
52. Akio N, Ryo N, Yukishige Y. Renal hypouricemia in school-aged children: screening of serum uric level before physical training. Pediatr Nephrol 2006;21:1898-900.
53. Sperling O. Hereditary renal hypouricemia. Mol Genet Metab 2006;89:14-8.
54. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006;55:3127-32.
55. Ohta T, Sakano T, Igarashi T, Itami N, Ogawa T. Exercise-induced acute renal failure associated with renal hypouricemia: Results of a questionnaire-based survey in Japan. Nephrol Dial Transplant 2004;19:1447-53.
56. DeCoek NM. Serum urate and urate clearance in diabetes mellitus. Aust Ann Med 1965;14:205-9.
57. Herman JB, Keynan A. Hyperglycemia and uric acid. Isr J Med Sci 1969;5:1048-52.
58. Shichiri M, Iwamoto H, Shiigai T. Diabetic renal hypouricemia. Arch Inter Med 1987;147:225-8.
59. Shichiri M, Iwamoto H, Marumo F. Diabetic hypouricemia as an indicator of clinical nephropathy. Am J Nephrol 1990;10:115-22.
60. Golik A, Weissgarten J, Cotariu D, Cohen N, Zaidenstein R, Ramot Y, et al. Renal uric acid handling in non-insulin-dependent diabetic patients with elevated glomerular filtration rates. Clin Sci 1993;85:713-6.
61. Erdberg A, Boner G, Van Dyk DJ, Carel R. Urine uric acid excretion in patients with insulin-dependent diabetes mellitus. Nephron 1992;60:134-7.
62. Recio JM, García Nieto V, Muñoz A, Pereyra F. Manejo tubular renal del ácido úrico en pacientes diagnosticados de diabetes mellitus tipo 1. Nefrologia 1999;19:482-3.
63. Durá Travé T, Moya Benavent M, Casero Ariza J. Hipouricemia renal en la diabetes mellitus infanto-juvenil. An Esp Pediatr 1996;44:425-8.
64. Magoula I, Tsapas G, Paletas K, Mavromatidis K. Insulin-dependent diabetes and renal hypouricemia. Nephron 1991;59:21-6.
65. González-Sicilia L, García-Están J, Martínez-Blázquez A, Fernández-Pardo J, Quiles JL, Hernández J. Renal metabolism of uric acid in type I insulin-dependent diabetic patients: Relation to metabolic compensation. Horm Metab Res 1997;29:520-3.
66. Goembiewska E, Ciechanowski K, Safranow K, Kedzierska K, Kabat-Koperska J. Renal handling of uric acid in patients with type 1 diabetes in relation to glycemic control. Arch Med Res 2005;36:32-5.
67. Keembiyehetty C, Augustin R, Carayannopoulos MO, Steer S, Manolescu A, Cheeseman CI, Moley KH. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol 2006;20:686-97.
68. Hisatome I, Sasaki N, Yamakawa M, Kobayashi M, Tanaka Y, Kosaka H, et al. Two cases of persistent hypouricemia associated with diabetes mellitus. Nephron 1992;61:191-9.
69. Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 2001;31:318-21.
70. Pitocco D, Di Stasio E, Romitelli F, Zaccardi F, Tavazzi B, Manto A, et al. Hypouricemia linked to an overproduction of nitric oxide is an early marker of oxidative stress in female subjects with type 1 diabetes. Diabetes Metab Res Rev 2008;24:318-23.
71. Ito O, Hasegawa Y, Sato K, Mitsui H, Yuda F, Sato H, et al. A case of exercise-induced acute renal failure in a patient with idiopathic renal hypouricemia developed during antihypertensive therapy with losartan and trichlormethiazide. Hypertens Res 2003;26:509-13.